Medicine and Dentistry
Sarcoma
100%
Neoplasm
96%
Soft Tissue Sarcoma
69%
Osteosarcoma
65%
Ifosfamide
42%
Pembrolizumab
42%
Clinical Trial
32%
Rhabdomyosarcoma
30%
Arm
30%
Adolescent
30%
Spindle Cell
29%
Drug Sensitivity
28%
Cancer Research
28%
Chordoma
28%
Pediatrics
28%
Disease
25%
Doxorubicin
22%
Combination Therapy
21%
Anticarcinogen
21%
Phosphotransferase Inhibitor
20%
Preoperative Radiotherapy
18%
Ewing Sarcoma
18%
Methotrexate
16%
Leiomyosarcoma
15%
Chondrosarcoma
15%
Cancer Therapy
15%
Gene Fusion
14%
Vincristine
14%
Etoposide
14%
Nirogacestat
14%
Pediatric Cancer
14%
Tropomyosin
14%
Combination Drug
14%
Epirubicin
14%
Anthracycline
14%
Phase II Trials
14%
Lid Margin Neovascularized Area
14%
Cyclophosphamide
14%
Regorafenib
14%
Tazemetostat
14%
4 Iodo 2,5 Dimethoxyamphetamine
14%
Adult Soft Tissue Sarcoma
14%
Spindle Cell Carcinoma
14%
Steady State
14%
Drug Megadose
14%
Oncology
14%
Receptor Tyrosine Kinase
14%
Protein
14%
Randomized Clinical Trial
14%
Pemetrexed
14%
Keyphrases
Tumor
40%
Ifosfamide
28%
GNAS mutation
28%
Spindle Cell Rhabdomyosarcoma
28%
Regorafenib
28%
Ewing Sarcoma
28%
Sarcoma
23%
Extremity Soft Tissue Sarcoma
21%
Phase II Study
21%
Soft Tissue Sarcoma
17%
Phase II Trial
15%
Soft Tissue Tumor
15%
Interaction Perspective
14%
Mechanism of Action
14%
Trial Results
14%
Nuclear Pore Complex
14%
Macrophages
14%
MyoD1
14%
Cyclin-dependent Kinase 4 (CDK4)
14%
ABL1
14%
Nirogacestat
14%
Poor Survival
14%
Diffuse Intrinsic Pontine Glioma
14%
Epirubicin
14%
PTEN mutation
14%
MEIS1-NCOA2
14%
Children's Oncology Group
14%
Stud
14%
PI3KCA mutation
14%
Anthracyclines
14%
Placebo-controlled
14%
Targeted Drugs
14%
Randomized Double-blind
14%
Ewing-like
14%
Single nucleotide Variant
14%
Placebo
14%
CSF1R
14%
Drug Perturbation
14%
Cold Spring
14%
Group Studies
14%
Pregnancy Outcome
14%
Tazemetostat
14%
During Pregnancy
14%
Surnames
14%
Functional Impact
14%
Treatment Refractory
14%
Liposarcoma
14%
Spindle Cell Tumor
14%
Functional Data
14%
Osteosarcoma
14%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
79%
Malignant Neoplasm
70%
Combination Therapy
47%
Clinical Trial
44%
Regorafenib
42%
Disease
33%
Osteosarcoma
33%
Giant Cell Tumor of Tendon Sheath
28%
Ewing Sarcoma
28%
Sarcoma
27%
Progression Free Survival
20%
Placebo
19%
Protein
18%
Anticarcinogen
18%
Receptor
16%
Hormone Receptor Blocking Agent
14%
Growth Disorder
14%
Letrozole
14%
Phase II Trials
14%
Nirogacestat
14%
Methotrexate
14%
Combination Drug
14%
Liposarcoma
14%
Colony Stimulating Factor 1
14%
Cytostatic Agent
14%
Breast Cancer
14%
Rhabdomyosarcoma
14%
2,5-Dimethoxy-4-iodoamphetamine
14%
Solid Malignant Neoplasm
14%
Chordoma
14%
Chimeric Protein
14%
Pemetrexed
14%
Predictive Modeling
9%
Soft Tissue Sarcoma
8%
Tumor Growth
7%
Phosphotransferase Inhibitor
7%
Fibrinogen
7%
Adverse Event
6%
Mouse
6%
Vincristine
5%